Aziyo Biologics Inc. (AZYO): Price and Financial Metrics


Aziyo Biologics Inc. (AZYO): $7.55

0.03 (+0.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AZYO Stock Price Chart Interactive Chart >

Price chart for AZYO

AZYO Price/Volume Stats

Current price $7.55 52-week high $18.20
Prev. close $7.52 52-week low $7.26
Day low $7.55 Volume 4,407
Day high $7.80 Avg. volume 21,667
50-day MA $8.23 Dividend yield N/A
200-day MA $11.73 Market Cap 77.23M

Aziyo Biologics Inc. (AZYO) Company Bio


Aziyo Biologics, Inc. operates as a biotechnology company which focuses on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties. It offers cardiac device envelope, vascular surgery, cardiothoracic repair, orthopedics and spine, sports medicine, dermal, and wound care. The company was founded on August 6, 2015 and is headquartered in Silver Spring, MD.


AZYO Latest News Stream


Event/Time News Detail
Loading, please wait...

AZYO Latest Social Stream


Loading social stream, please wait...

View Full AZYO Social Stream

Latest AZYO News From Around the Web

Below are the latest news stories about Aziyo Biologics Inc that investors may wish to consider to help them evaluate AZYO as an investment opportunity.

Aziyo Biologics to Participate in the 2021 Cantor Global Healthcare Conference

SILVER SPRING, Md., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the Company will participate in the upcoming 2021 Cantor Global Healthcare Conference. Date: Monday, September 27, 2021Format: Presentation at 8:40 AM ETA link to the presentation will be available on the “Investors” sec

Yahoo | September 15, 2021

Aziyo Biologics Appoints Peter G. Edwards as General Counsel

SILVER SPRING, Md., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the appointment of Peter G. Edwards as General Counsel. “We are delighted to welcome such a strong and experienced leader as Peter to our executive team,” said Ron Lloyd, President and Chief Executive Officer of Aziyo. “W

Yahoo | August 31, 2021

The Aziyo Biologics, Inc. (NASDAQ:AZYO) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Aziyo Biologics, Inc. ( NASDAQ:AZYO ) shareholders are probably feeling a little disappointed, since its shares fell...

Yahoo | August 15, 2021

Aziyo Biologics Reports Second Quarter 2021 Financial Results

SILVER SPRING, Md., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the three and six months ended June 30, 2021. Recent Highlights Recorded net sales of $12.2 million for the second quarter of 2021, representing a 42% increase over the second quarter of 2020 Core Pro

Yahoo | August 9, 2021

Aziyo Biologics to Report Second Quarter 2021 Financial Results on Monday, August 9, 2021

SILVER SPRING, Md., July 26, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it plans to release its second quarter earnings results after market close on Monday, August 9, 2021. Management will host a conference call to review the companys financial performance starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast.

Intrado Digital Media | July 26, 2021

Read More 'AZYO' Stories Here

AZYO Price Returns

1-mo -7.36%
3-mo -29.90%
6-mo -48.57%
1-year N/A
3-year N/A
5-year N/A
YTD -44.61%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7725 seconds.